Answers are grounded in this paper and cite their sources.
Our preliminary data show that erlotinib inhibits Triple-negative breast cancer (TNBC) in a xenograft model. However, inhibition of metastasis by erlotinib is accompanied by nonspecific effects because erlotinib can inhibit other kinases; thus, more direct targets that regulate TNBC metastasis need to be identified to improve its therapeutic efficacy.
No takes yet. Share an insight, caveat, or question.
Ueno et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: